Analysis and Commentary STEVEN GROSSMAN 3/5/20 Analysis and Commentary STEVEN GROSSMAN 3/5/20 Additional funding for FDA; more Qs and As Read More Analysis and Commentary STEVEN GROSSMAN 2/27/20 Analysis and Commentary STEVEN GROSSMAN 2/27/20 More Qs and As About the FY 21 Appropriation Process Read More Analysis and Commentary STEVEN GROSSMAN 2/21/20 Analysis and Commentary STEVEN GROSSMAN 2/21/20 TMAP: Planning for Efficient, Effective Data Management at FDA Read More Analysis and Commentary STEVEN GROSSMAN 2/14/20 Analysis and Commentary STEVEN GROSSMAN 2/14/20 The Alliance's Assessment of the President's FY 21 Budget Request Read More Analysis and Commentary STEVEN GROSSMAN 2/7/20 Analysis and Commentary STEVEN GROSSMAN 2/7/20 Shuren Fills Alliance in on Fast-Moving Science and CDRH Needs Read More Analysis and Commentary STEVEN GROSSMAN 2/1/20 Analysis and Commentary STEVEN GROSSMAN 2/1/20 FDA's FY 21 Appropriation: What's Happening When? Read More Analysis and Commentary STEVEN GROSSMAN 1/25/20 Analysis and Commentary STEVEN GROSSMAN 1/25/20 Alliance Learns About CBER Priorities for 2020 and Beyond Read More Analysis and Commentary STEVEN GROSSMAN 1/17/20 Analysis and Commentary STEVEN GROSSMAN 1/17/20 Hill Day and Other Upcoming Alliance Advocacy Initiatives Read More Analysis and Commentary STEVEN GROSSMAN 1/10/20 Analysis and Commentary STEVEN GROSSMAN 1/10/20 FDA Is Its People Read More Analysis and Commentary STEVEN GROSSMAN 12/20/19 Analysis and Commentary STEVEN GROSSMAN 12/20/19 Success Again in 2019 ... Building Support for 2020 Read More Analysis and Commentary STEVEN GROSSMAN 12/16/19 Analysis and Commentary STEVEN GROSSMAN 12/16/19 FDA's "Appropriation Fate" Is Evaluated on a Daily Basis Read More Analysis and Commentary STEVEN GROSSMAN 12/8/19 Analysis and Commentary STEVEN GROSSMAN 12/8/19 Three Key Questions ... and the Answers Read More Analysis and Commentary STEVEN GROSSMAN 11/22/19 Analysis and Commentary STEVEN GROSSMAN 11/22/19 Time to Talk Turkey ... Once Again Read More Analysis and Commentary STEVEN GROSSMAN 11/15/19 Analysis and Commentary STEVEN GROSSMAN 11/15/19 FY 20 Appropriations: More Qs; More As Read More Analysis and Commentary STEVEN GROSSMAN 11/11/19 Analysis and Commentary STEVEN GROSSMAN 11/11/19 FY 20 Appropriations: How, When, and Why? Read More Analysis and Commentary STEVEN GROSSMAN 11/1/19 Analysis and Commentary STEVEN GROSSMAN 11/1/19 Another Perspective on the FY 20 Tea Leaves Read More Analysis and Commentary STEVEN GROSSMAN 10/25/19 Analysis and Commentary STEVEN GROSSMAN 10/25/19 Establishing Order: The Chickens and the Eggs Read More Analysis and Commentary STEVEN GROSSMAN 10/19/19 Analysis and Commentary STEVEN GROSSMAN 10/19/19 Is Another Shutdown a Real Possibility? Read More Analysis and Commentary STEVEN GROSSMAN 10/5/19 Analysis and Commentary STEVEN GROSSMAN 10/5/19 Full-Year CR: Better Than a Shutdown, But ... Read More Analysis and Commentary STEVEN GROSSMAN 9/30/19 Analysis and Commentary STEVEN GROSSMAN 9/30/19 "Wouldn't It Be Wonderful" Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 3/5/20 Analysis and Commentary STEVEN GROSSMAN 3/5/20 Additional funding for FDA; more Qs and As Read More
Analysis and Commentary STEVEN GROSSMAN 2/27/20 Analysis and Commentary STEVEN GROSSMAN 2/27/20 More Qs and As About the FY 21 Appropriation Process Read More
Analysis and Commentary STEVEN GROSSMAN 2/21/20 Analysis and Commentary STEVEN GROSSMAN 2/21/20 TMAP: Planning for Efficient, Effective Data Management at FDA Read More
Analysis and Commentary STEVEN GROSSMAN 2/14/20 Analysis and Commentary STEVEN GROSSMAN 2/14/20 The Alliance's Assessment of the President's FY 21 Budget Request Read More
Analysis and Commentary STEVEN GROSSMAN 2/7/20 Analysis and Commentary STEVEN GROSSMAN 2/7/20 Shuren Fills Alliance in on Fast-Moving Science and CDRH Needs Read More
Analysis and Commentary STEVEN GROSSMAN 2/1/20 Analysis and Commentary STEVEN GROSSMAN 2/1/20 FDA's FY 21 Appropriation: What's Happening When? Read More
Analysis and Commentary STEVEN GROSSMAN 1/25/20 Analysis and Commentary STEVEN GROSSMAN 1/25/20 Alliance Learns About CBER Priorities for 2020 and Beyond Read More
Analysis and Commentary STEVEN GROSSMAN 1/17/20 Analysis and Commentary STEVEN GROSSMAN 1/17/20 Hill Day and Other Upcoming Alliance Advocacy Initiatives Read More
Analysis and Commentary STEVEN GROSSMAN 1/10/20 Analysis and Commentary STEVEN GROSSMAN 1/10/20 FDA Is Its People Read More
Analysis and Commentary STEVEN GROSSMAN 12/20/19 Analysis and Commentary STEVEN GROSSMAN 12/20/19 Success Again in 2019 ... Building Support for 2020 Read More
Analysis and Commentary STEVEN GROSSMAN 12/16/19 Analysis and Commentary STEVEN GROSSMAN 12/16/19 FDA's "Appropriation Fate" Is Evaluated on a Daily Basis Read More
Analysis and Commentary STEVEN GROSSMAN 12/8/19 Analysis and Commentary STEVEN GROSSMAN 12/8/19 Three Key Questions ... and the Answers Read More
Analysis and Commentary STEVEN GROSSMAN 11/22/19 Analysis and Commentary STEVEN GROSSMAN 11/22/19 Time to Talk Turkey ... Once Again Read More
Analysis and Commentary STEVEN GROSSMAN 11/15/19 Analysis and Commentary STEVEN GROSSMAN 11/15/19 FY 20 Appropriations: More Qs; More As Read More
Analysis and Commentary STEVEN GROSSMAN 11/11/19 Analysis and Commentary STEVEN GROSSMAN 11/11/19 FY 20 Appropriations: How, When, and Why? Read More
Analysis and Commentary STEVEN GROSSMAN 11/1/19 Analysis and Commentary STEVEN GROSSMAN 11/1/19 Another Perspective on the FY 20 Tea Leaves Read More
Analysis and Commentary STEVEN GROSSMAN 10/25/19 Analysis and Commentary STEVEN GROSSMAN 10/25/19 Establishing Order: The Chickens and the Eggs Read More
Analysis and Commentary STEVEN GROSSMAN 10/19/19 Analysis and Commentary STEVEN GROSSMAN 10/19/19 Is Another Shutdown a Real Possibility? Read More
Analysis and Commentary STEVEN GROSSMAN 10/5/19 Analysis and Commentary STEVEN GROSSMAN 10/5/19 Full-Year CR: Better Than a Shutdown, But ... Read More
Analysis and Commentary STEVEN GROSSMAN 9/30/19 Analysis and Commentary STEVEN GROSSMAN 9/30/19 "Wouldn't It Be Wonderful" Read More
